TCTR20141119002已完成未知
Incidence of Post-intravitreal Anti-VEGF Endophthalmitis at Thammasat University Hospital
faculty of Medicine, Thammasat University0 个研究点目标入组 1,167 人开始时间: 2014年11月19日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,167
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 30 Years 至 80 Years（—）
- 性别
- All
入选标准
- •patient with endophthalmitis secondary to therapeutic intravitreal ranibizumab and bevacizumab injections
排除标准
- •unreliable medical record
研究者
相似试验
进行中（未招募）
1 期
To Study Aqueous Humor Composition and Retinal Imaging Features in Response to Anti-VEGF in Neovascular Age-Related Macular Degeneration and Diabetic Macular EdemaTreatment Naïve Neovascular Age-Related Macular Degeneration (nAMD) and Treatment Naïve diabetic macular edema (DME)MedDRA version: 20.0Level: SOCClassification code 10015919Term: Eye disordersSystem Organ Class: 10015919 - Eye disordersEUCTR2020-003515-10-PLF. Hoffmann-La Roche Ltd200
进行中（未招募）
1 期
To Study Aqueous Humor Composition and Retinal Imaging Features in Response to Anti-VEGF in Neovascular Age-Related Macular Degeneration and Diabetic Macular EdemaEUCTR2020-003515-10-ITF. HOFFMANN - LA ROCHE LTD.200
进行中（未招募）
1 期
To Study Aqueous Humor Composition and Retinal Imaging Features in Response to Anti-VEGF in Neovascular Age-Related Macular Degeneration and Diabetic Macular EdemaTreatment Naïve Neovascular Age-Related Macular Degeneration (nAMD) and Treatment Naïve diabetic macular edema (DME)MedDRA version: 20.0Level: SOCClassification code 10015919Term: Eye disordersSystem Organ Class: 10015919 - Eye disordersEUCTR2020-003515-10-CZF. Hoffmann-La Roche Ltd200
已完成
不适用
Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to LucentisWet AMDNCT00804934Retina Institute of Hawaii100
尚未招募
不适用
Evaluation of the responsiveness of anti-VEGF treatment in DMEdiabetic retinopathy (DR)NL-OMON29053GSMS70